Since last few years, blister packaging format has been the preferred choice by pharmaceutical industries for packaging oral drugs and the consequence is anticipated to remain same going forward due to increasing demand for packaging in upcoming years. Moreover, the availability of multi-layer and mono layer blister packs meet the requirement of pharmaceutical companies and attracts large number of market players in the market during the forecast period.
According to Data Bridge Market Research the Pharmaceutical Blister Packaging Market accounted for USD 6.55 billion in 2021, and expected to reach USD 10.39 billion by 2029. The market is expected to grow with a CAGR of 5.60% in the forecast period of 2022 to 2029.
“Various advantageous properties associated with pharmaceutical blister packaging”
The most durable packaging in the pharmaceutical sector is blister packing, which helps to protect different pharmaceutical products from air, humidity, and moisture because contact with these might cause contamination. Blister packaging is the best packaging for protecting medications, enhancing dosage compliance, and quickly adapting to the product design. The market is anticipated to exhibit a positive growth trend during the forecast period as a result of the above mentioned factors.
What restraints the growth of Pharmaceutical Blister Packaging Market?
“Stringent regulations for using pharmaceutical blister packaging”
Government restrictions on the use of pharmaceutical blister packaging may serve as a significant barrier in some cases. It increased total cost of manufacturing process which reduces the profit to the manufacturers. For instance, the U.S. government has approved stringent set of specification under regulation USP 34 NF 29 and US 21 CFR for controlling the quality of the packaging material. Thus, these stringent standards are anticipated to hinder the growth of the pharmaceutical blister packaging market during the forecast period.
Segmentation: Pharmaceutical Blister Packaging Market
The pharmaceutical blister packaging market is segmented on the basis of product type, technology type, material and application.
- On the basis of product type, the pharmaceutical blister packaging market is segmented into clamshell, carded.
- Based on technology type, the pharmaceutical blister packaging market is segmented into cold forming, thermoforming.
- On the basis of material, the pharmaceutical blister packaging market is segmented into polyethylene terephthalate (PET, PETE, PETG or polyester), high density polyethylene (HDPE), polyvinyl chloride (PVC), low density polyethylene (LDPE), aluminum, paper and paper board.
- On the basis of application, the pharmaceutical blister packaging market is segmented into tablets, capsules, powders, medical devices.
Regional Insights: North America is expected to dominate the Pharmaceutical Blister Packaging Market
North America is expected to dominate the market and is expected to grow significantly owing to the major presence of pharmaceutical companies in this region. Furthermore, increasing funding towards research and development activities and availability of advanced technological research platforms are some of the other major factors which will further increase the market growth in this region.
- In addition, the Asia-Pacific region is likely to register highest growth rate during the forecast period of 2022 to 2029 owing to growing pharmaceutical production in this region. Furthermore, a sizeable patient pool, increasing consumer awareness regarding blister packaging, and rising need for novel packaging materials are some of the other major factors that will further boost propel the market growth in this region.
To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-pharmaceutical-blister-packaging-market
Recent Developments in Pharmaceutical Blister Packaging Market
- In 2022, a strong traceability system was established throughout the manufacturing process with the introduction of smart containers by German pharmaceutical glass manufacturer Schott AG. These containers are laser-marked with a distinctive identity. Now, manufactures of pharmaceuticals industry using digital technology. A laser and a distinct identification are used to mark each Smart Container, providing unprecedented traceability throughout the production process. This novel idea enables pharmaceutical manufacturers to utilize big data analytics and machine vision on pharmaceutical filling lines. The German company claims that line clearing and rejecting management can both be enhanced by the new technology.
The Prominent Key Players Operating in the Pharmaceutical Blister Packaging Market Include:
- Schott (Germany)
- Amcor plc (Switzerland)
- Dow (U.S.)
- AptarGroup, Inc., (U.S.)
- Klöckner Pentaplast (Germany)
- West Pharmaceutical Services, Inc. (U.S.)
- Berry Global Inc. (U.S.)
- Honeywell International, Inc. (U.S)
- ACG (India)
- Nipro (Japan)
- Gerresheimer AG (Germany)
- Catalent Inc., (U.S.)
- WestRock Company (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of Pharmaceutical Blister Packaging Market companies contact, https://www.databridgemarketresearch.com/reports/global-pharmaceutical-blister-packaging-market
Research Methodology: Global Pharmaceutical Blister Packaging Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
